Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsDetails on the new premiums are still being deliberated among the Finance Ministry, Health Ministry and the Health Care and Social Security Agency (BPJS Kesehatan), before being submitted to the House of Representatives for further discussions.
Raising National Health Insurance (JKN) premiums may be necessary to ensure the sustainability of the program, but the government should refrain from making a dramatic increase like it did in 2020, an observer has warned.
The Healthcare and Social Security Agency (BPJS Kesehatan) has said a recent regulation on standardized inpatient care for National Health Insurance (JKN) policyholders will not affect premiums for at least a year.
When the COVID-19 pandemic hit Indonesia in March, South Tangerang, Banten, resident Tinto Arianto Wibowo's 2-year-old son's hospital visits became even more frequent, draining him financially. His son had long suffered fevers, coughing and a lump on his neck and hospitals now suspected him of having COVID-19.
The new regulation will take effect in July but to the opposition of lawmakers and experts who not only accused the government of undermining the rule of law but also criticized its timing, as millions of people had been badly hit by the pandemic
Critics have predicted that Indonesia will see a surge in people downgrading their national health insurance plans following a decision by the government to increase premiums, saying it will hinder access to health care for lower class policyholders.
After being criticized for undermining the rule of law in a series of COVID-19 pandemic response policies, the government is under scrutiny once again for reviving a national health insurance (JKN) premium hike after it was annulled by the Supreme Court.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.